A Unique and Engaging Experience

Roundtables are special ticketed sessions (only $30 per session in advance/$35 per session onsite*) taking place Monday – Wednesday as 1-hour interactive small group discussions with up to 10 participants. These small groups allow for a unique and highly engaging experience where participants get direct interaction with the presenter and opportunities to both learn and ask. Each Roundtable is presented twice, once in the morning (7:30 – 8:30 a.m.) and once during mid-day (12:30 – 1:30 p.m.). Seating is very limited. Visit the Online Session Search for the latest availability. Visit Registration Resource Center to add ticketed event to your existing registration.

Register Now
Online Session Search

Browse by day to explore Roundtables to make the most of your ADLM 2024 experience.

Browse by Day

Each Roundtable is presented twice, once in the morning (7:30 – 8:30 a.m.) and once during mid-day (12:30 – 1:30 p.m.). 

Monday, July 29

Tuesday, July 30 

Wednesday, July 31 

Monday, July 29

42101/52201 Health Equity in the Laboratory: Re-evaluating the Role of Sex and Race in Reference Interval Determinations
Katie Troike, PhD, Cleveland Clinic

42102/52202 Preanalytical Factors in Blood Gas Analysis
Xander van Wijk, PhD, DABCC, FADLM, Van Wijk Consulting, LLC

42103/52203 Advancing Inclusivity in Healthcare: Enhancing Clinical Laboratory Practices for Transgender Patient Care
Leah Militello, MD, MBA, Yale University

42104/52204 Standardization of Testosterone and Estradiol Measurements by the CDC Clinical Standardization Programs: A Comprehensive Approach Going Beyond Calibration
Tatiana Buchannan, BS, Centers for Disease Control and Prevention

42105/52205 Heavy Alcohol Use: How to Identify It in the Lab
Jacob Nielsen, PhD, Houston Methodist Hospital

42106/52206 A Roadmap for Developing LC-MS/MS Methods for Large Pain Management Drug Test Panels
Sheng Feng, PhD, DABCC, Boston University

42107/52207 A Practical Guide to Implementing Moving Averages
Sheng-Ying Lo, PhD, DABCC, Geisinger Medical Laboratories

42108/52208 Future-proofing Your Clinical Instrumentation Upgrade: A Roadmap for Optimizing Clinical Instrumentation to Meet Tomorrow's Challenges
Xu Li, PhD, ASCP, NRCC, Emory University

42109/52209 Collect It Yourself! Hands-on Overview of Diverse Specimen Collection Devices for Home Use and the Role of the Clinical Laboratory
Ria Fyffe-Freil, PhD, University of Nebraska Medical Center

42110/52210 Unveiling Toxicological Enigmas: Interpreting Complex Toxicology Cases in Different Matrices
Ibrahim Choucair, PhD, University of Kentucky College of Medicine

42111/52211 Evaluation of Fentanyl and Xylazine in Emergency Department Patients
Catherine Mills, PhD, Medical University of South Carolina

42112/52212 Translating Theory into Action: Practical Approaches for Optimizing Therapeutic Drug Monitoring Services
William Butler, PhD, Hospital of the University of Pennsylvania

42113/52213 ANA Testing on HEp-2 Cells: How Automation and ICAP Can Help With Standardization
Vincent Ricchiuti, PhD, ABB, FADLM, Labcorp

42114/52214 Maximizing the Potential of Gene Therapy: The Clinical Laboratory?s Role in Pre-screening Patients for Adeno-associated Virus Serotype 9 (AAV9) Vector Immunity
Jingcai Wang, MD, PhD, ASCP, NRCC, Nationwide Children's Hospital

42115/52215 Process Improvement for Protein Electrophoresis and Immunofixation: Workflow Automation and Remote Sign-out
Xiaochun Zhang, MD, PhD, DABCC, ABMLI, HCLD, University Hospitals Cleveland Medical Center

42116/52216 Laboratory Assessment of Acquired Thrombocytopenia: A Case Based Approach
Olajumoke Oladipo, MD, MSc, DABCC, FADLM, Penn State Milton S. Hershey Medical Center

42117/52217 Current Trends in Thyroid Auto-Antibodies Testing
Damien Gruson, PhD, Cliniques Universitaires St-Luc

42118/52218 Ensuring Quality Measurements of Emerging and Traditional Biomarkers for Cardiovascular Diseases: The CDC Cardiovascular Disease Biomarker Standardization Programs
Alicia Lyle, PhD, FAHA, Centers for Disease Control and Prevention

42119/52219 Strategies for Effective Laboratory Test Utilization
Ridwan Ibrahim, PhD, Baylor College of Medicine/ Texas Children's Hospital

42120/52220 CSI DIY: Leveraging Your Laboratory Information System to Establish Methods for Conducting Specimen Integrity Investigations
Ashley Rackow, PhD, Johns Hopkins University

42121/52221 Implementing a New Test or a New Instrument? A Crash Course on Method Validation
Kornelia Galior, PhD, DABCC, FADLM, University of Wisconsin, Madison

42122/52222 Laboratory Stewardship: Tests Pending at Discharge
Andrew Fletcher, MD, MBA. CPE, CHCQM, Eutilogic consulting

42123/52223 Improving the Timeliness of Test Results: A Symphony of Process, TAT, and Quality!
Vrajesh Pandya, PhD, DABCC, University of Utah/ARUP Laboratories

42124/52224 How Often to Repeat the Test: Importance and Challenges of Minimal Retesting Interval
Asmita Hazra, MD, All India Institute of Medical Sciences, Kalyani

42125/52225 Host-Response Serum Biomarkers to Distinguish Bacterial From Viral Infections: Clinical and Economic Impact Analysis of the MeMed BV Assay
Alejandro Zuretti, MD, SUNY Downstate

42126/52226 BNP or NT-proBNP: Which is the Better Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
Madhusudhanan Narasimhan, PhD, MHA, UT Southwestern Medical Center

42127/52227 Leaving No One Behind: Management of Hyperbilirubinemia in Preterm Infants Less Than 35 Weeks' Gestation with Clinical Decision Support Tools
Yi Xiao, PhD, DABCC, CLS, Children's Hospital Los Angeles

42128/52228 Data Analysis in R: Lowering the Barrier to Entry for the Clinical Laboratory
Benjamin Andress, PhD, MLS(ASCP), Mayo Clinic

42129/52229 Quality Control In Molecular Biology Laboratories
Ashwini Kumar Nepal, MS, MLS(ASCP), PPD, part of Thermo Fisher Scientific

42130/52230 Emerging Technologies to Enable Remote Sampling for Greater Health Equity
Shen Luan, PhD, Thermo Fisher Scientific

Back to Top


Tuesday, July 30

43101/53201 The Cardiopulmonary Bypass Adjustment at the Point-of-Care Measurement of Hematocrit and Hemoglobin: When to Use and When Not To?
Mustafa Barbhuiya, PhD, UMass Chan Medical School-Baystate Medical Center

43102/53202 Party of 1 at the Point-of-Care Table? Add a Seatmate!
Peggy Mann, MS, MT (ASCP), CPP, University of Texas Medical Branch

43103/53203 Point-of-Care Testing: Figuring Out How Many Point-of-Care Staff Are Needed
Kathleen David, BA, ASCP, MT (ASCP), Tricore Reference Laboratories

43104/53204 How People Try to Beat Drug Testing and Defend Positive Results
Amitava Dasgupta, PhD, DABCC, University of Kansas Medical Center

43105/53205 From Theory to Reality: A Closer Look at Toxicology Screens for Drugs of Abuse
Imir Metushi, PhD, DABCC, University of California, Los Angeles David Geffen School of Medicine

43106/53206 Where’d That Flag Come From? Therapeutic Ranges and Critical Action Values for Psychoactive Drugs
Bernice Agana, PhD, Johns Hopkins University

43107/53207 Designing Clinical Context-Specific Drug Test Panels
Anil Kiran Chokkalla, PhD, Baylor College of Medicine

43108/53208 Practical Guidance for Evaluating and Selecting Automated Chemistry Analyzers to Implement in Academic Clinical Laboratories
Stefani Thomas, PhD, DABCC, NRCC, University of Minnesota

43109/53209 Assay Interference: Tracking Analytical Difficulties in a Central Automated Lab Setting
Ruhan Wei, PhD, DABCC, NRCC, Duke University Health System

43110/53210 Standardization and Integration of Chemistry Laboratories Across the Health System
Melissa Ulas, MD, PhD, NRCC, SCYM(ASCP), Temple University Health System

43111/53211 Diagnostic Blood Loss: Why It Is of Concern and How to Minimize It
Saptarshi Mandal, MD, MS, All India Institute of Medical Sciences

43112/53212 Laboratory Lament: Cracking the Code on Clinical Workforce Woes
Marc Rumpler, PhD, ASCP, DABCC, NRCC, FADLM, One Lambda Laboratories, part of Thermo Fisher Scientific

43113/53213 Lab Injuries and Exposures: The Real Data
Dan Scungio, MLS (ASCP), SLS, CQA (ASQ), CHOP, Sentara Health

43114/53214 Transitioning to Green Labs: Strategies for Overcoming Challenges on the Journey to Sustainable Laboratory Practices
Aylin Sepici, MD, PhD, Gazi University

43115/53215 Understanding the Impact of Blood Collection Tube Components on Clinical Assays: A Practical Guide for Managing Supply Chain Disruptions and Beyond
Raffick Bowen, PhD, MHA, MLT(CSMLS), DABCC, DCLCHEM, FADLM, FCACB, Stanford University

43116/53216 Investigating and Documenting Unacceptable Proficiency Testing Results
Sheng-Ying Lo, PhD, DABCC, Geisinger Medical Laboratories

43117/53217 Method Verification for ISO 15189:2022 Medical Laboratories: Requirements for Quality and Competence
Alison Bransfield, MS, Cork University Hospital

43118/53218 Sweat Testing: Current Practices and Quality Metrics
Daisy Unsihuay Vila, PhD, Hospital of the University of Pennsylvania

43119/53219 Considerations of HbA1c Measurement
Shu-Ling Fan, PhD, DABCC, FADLM, Vanderbilt University Medical Center

43120/53220 Challenges in Primary Hyperparathyroidism: Unexpectedly Elevated Parathyroid Hormone Concentrations and the Importance of Careful Testing
Shaimaa Maher, PhD, Cleveland Clinic

43121/53221 No Need to Get Testy: Breaking Down Testosterone Methodology and Utilization
Katie Troike, PhD, Cleveland Clinic

43122/53222 Gels From Hell: Overcoming Difficult-To-Interpret Serum Protein Electrophoresis and Immunofixation Test Findings
Robert Maynard, PhD, NRCC, University of Kentucky

43123/53223 Methodologies for Detection of Monoclonal Immunoglobulins and Identification of Therapeutic Monoclonal Antibodies
Vishnu Amaram Samara Simha Subhash Chandra, PhD, University of Chicago

43124/53224 HIV Diagnostics: What's Next?
Vincent Ricchiuti, PhD, ABB, FADLM, Labcorp

43125/53225 What the HIL?!? Refining Vendor Interference Claims to Work for Your Laboratory
Anna Merrill, PhD, DABCC, University of Iowa Hospitals and Clinics

43126/53226 Unique Considerations for Method Validation and Quality Control of Semi-Quantitative Tests
Uvaraj Uddayasankar, PhD, FCACB, LifeLabs

43127/53227 This Result Does Not Make Sense: Unexpected Results Related to the Patient's Condition
Monica Ianosi-Irimie, MD, PhD, Cooper University Hospital

43128/53228 Reduced Hemolysis and Outliers in High Sensitivity Troponin Testing
Hind Malaeb, PhD, Yale University

43129/53229 Implementation of Alert System for Early Diagnosis of Acute Kidney Injury
Barnali Das, MD, FADLM, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute

43130/53230 Digital Microscopy and Artificial Intelligence Cell Pre-Classification in the Hematology Laboratory
Megan Nakashima, MD, Cleveland Clinic

Back to Top


Wednesday, July 31

44101/54201 Delta Check Performance Assessment by Using Real-World Data and Receiver Operating Characteristic Curves
Melissa Ulas, MD, PhD, NRCC, SCYM(ASCP), Temple University Health System

44102/54202 Computerized Provider Order Entry Decision Support Tool for Monoclonal Gammopathies Screening
Hoi-Ying Yu, PhD, DABCC, FADLM, Geisinger Health System

44103/54203 Prostate-Specific Antigen Testing in Men Under 50: Challenging the Limitations and Shaping the Future of Prostate Cancer Screening
Lechuang Chen, PhD, The University of Texas MD Anderson Cancer Center

44104/54204 Enhancing Analytical Testing Efficiency with Sigma Metrics in Emergency Laboratories
Amani Gusti, PhD, MSc, King Fahd Armed Forces Hospital

44106/54206 High-Sensitivity Cardiac Troponin Assays: Implementation of Standardization and Sex-Specific Upper Reference Limits Is the Need of the Hour
Barnali Das, MD, FADLM, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute

44107/54207 The Impact of Multiplex Molecular Panel Utilization on the Healthcare Continuum
Christopher Crossett, PhD, MBA, MHA, Accumen

44108/54208 Missing Specimens: Lessons Learned and Continuous Quality Improvement
Siew-Kim Ong, BS, MS, MBA, EDD, ASCP, Sengkang General Hospital

44109/54209 New Electronic Health Record System: CAP Requirements, Validation Process, and Post Go-Live Discoveries
Kyle Lund, PhD, DABCC, Landstuhl Regional Medical Center

44110/54210 Optimizing Laboratory Medicine Through Strategic Planning
Mahesheema Ali, PhD, NRCC, FADLM, The Metro Health

44111/54211 Get More Accomplished: Sharing Ways to Improve Operational Efficiency
Susan Dawson, MBA, BA, MT (ASCP), Swedish Hospital part of NorthShore Edwards Elmhurst Health

44112/54212 Standardizing Vitamin D Tests: Progress and Challenges Observed by the CDC Clinical Standardization Programs
Otoe Sugahara, BS, Centers for Disease Control and Prevention

44113/54213 Unlocking the Mind: Alzheimer's Disease Biomarkers for Early Detection and Treatment
Hannah Brown, PhD, Washington University in St. Louis

44114/54214 I Know I Should Use a Reference Material, but How?
Karen Phinney, PhD, National Institute of Standards and Technology

44115/54215 How Blood Tests Are Affected by Transfusion or Apheresis
Saptarshi Mandal, MD, MS, All India Institute of Medical Sciences

44116/54216 The Ever-Increasing Challenges of Detecting and Interpreting Monoclonal Proteins
John Oyelakin-Ogunbileje, PhD, MSc, DABCC, NRCC, ASCP(SC), Indiana University

44117/54217 Serology Tests for Celiac Disease Diagnosis in Children
Run Zhang Shi, MD, PhD, Stanford Medical Center Clinical Laboratories

44118/54218 Implementing Best Practices for CYP2D6 Pharmacogenetic Testing
James Canner, PhD, NRCC, Gravity Diagnostics

44119/54219 Heparin-Induced Thrombocytopenia Testing, Method Selections, and Need of Confirmatory Testing
Mustafa Barbhuiya, PhD, UMass Chan Medical School-Baystate Medical Center

44120/54220 Capillary Electrophoresis for Hemoglobin Evaluation: A Case-Based Approach to Learning Hemoglobinopathy and Thalassemia Basics
Mark Girton, BS, MD, Clinical Chemistry, Hematopathology, University of Michigan

44121/54221 Mass Spectrometry Assays for Protein Quantification in the Clinical Laboratory
Yanchun Lin, PhD, Washington University in St Louis

44122/54222 A Step-By-Step Guide for Small Molecule LC-MS/MS Method Development and Validation
Cody Orahoske, PhD, University of California, San Francisco

44123/54223 So, You Want to Test for Fentanyl in Your Lab?
Marlen Menlyadiev, PhD, NRCC, Geisinger Health System

44124/54224 Establishing a Toxicology Laboratory: Lessons Learned Along the Way
Rejwi Dahal, PhD, DABCC, NRCC, Indiana University School of Medicine

44125/54225 Recent Developments in Improving Pediatric Reference Intervals
Li Zha, PhD, DABCC, NRCC, Beth Israel Deaconess Medical Center

44126/54226 Newborn Screening and Follow-up for Metabolic Disorders
Uttam Garg, PhD, DABCC, NRCC, FABFT, FADLM, Childrens Mercy Hospital

44127/54227 Advancing Thyroid Function Testing Through the CDC Standardization Programs: Improving Accuracy and Reliability of Measurements
Uliana Danilenko, PhD, Centers for Disease Control and Prevention

44128/54228 Unraveling the Intricacies of Adrenal Venous Sampling (AVS): Challenges, Best Practices, and the Path Forward in Laboratory Integration
Guanmin Chen, PhD, The University of Chicago

Back to Top